480 likes | 1.34k Views
Temporary and Permanent Cardiac Pacing. IntroductionTemporary pacing : Indications, TechniquePermanent Pacing : Pacemaker Nomenclature Indications Selection of Pacing Mode Pacing for Hemodynamic Improvement Pacemaker Implantation, Complication
E N D
1. Pacemakers and Implantable Cardioverter Defibrillators
2. Temporary and Permanent Cardiac Pacing Introduction
Temporary pacing : Indications, Technique
Permanent Pacing :
Pacemaker Nomenclature
Indications
Selection of Pacing Mode
Pacing for Hemodynamic Improvement
Pacemaker Implantation, Complications
Implantable Cardioverter Defibrillator
3. Temporary Cardiac Pacing Transvenous
Transcutaneous
Epicardial
Transesophageal
4. Indications for Temporary Pacing Acute myocardial infarction with:
CHB, Mobitz type 2 AV block, medically refractory symptomatic bradycardia, alternating BBB, new bifascicular block, new BBB with anterior MI
In absence of acute MI : SSS, CHB, Mobitz type 2 AV block
Treatment of tachyarrhythmias : VT
5. Temporary Transvenous Pacing Unipolar Electrograms
6. Paced QRS Morphology
7. Permanent Pacing
8. The Pacemaker System Patient
9. Pacemaker Implantation Epicardial
Transvenous :
Generator implanted anterior to pectoral muscle
Atrial/Ventricular leads via subclavian or cephalic vein
Sensing and pacing threshold
Chest X-ray for pneumothorax, lead position
12. Acute Complications of Pacemaker Implantation Venous access
Pneumothorax, hemothorax
Air embolism
Perforation of central vein
Inadvertent arterial entry
Lead placement
Brady – tachyarrhythmia
Perforation of heart, vein
Damage to heart valve
Generator
Pocket hematoma
Improper or inadequate connection of lead
13. Delayed Complications of Pacemaker Therapy Lead-related
Thrombosis/embolization
SVC obstruction
Lead dislodgement
Infection
Lead failure
Perforation, pericarditis
Generator-related
Pain
Erosion, infection
Migration
Damage from radiation, electric shock
Patient-related
Twiddler syndrome
14. Codes Describing Pacemaker Modes
15. DDD
16. Indications for Pacing for AV Block
17. Indications for Pacing for Sinus Node Dysfunction
18. 18 Mode Selection Considerations
Status of Atrial Rhythm - Intrinsic vs. Paced - Presence of Atrial Tachyarrhythmias:
Acute/Chronic
Status of AV Conduction
Normal -Slowed-Blocked
Presence of Chronotropic Incompetence
19. Today’s Sensors Vibration
non-physiologic
Acceleration
non-physiologic
Minute Ventilation
physiologic
Temperature
physiologic
20. Case #1 72 year old male with chronic atrial fibrillation of greater than 10 years’ duration is admitted following a syncopal episode. A 2D echo shows LVEF 60%. Telemetry reveals atrial fibrillation with slow ventricular response and pauses of 4 to 7 seconds associated with lightheadedness.
How would you proceed?
21. Case #1 72 year old male with chronic atrial fibrillation of greater than 10 years’ duration is admitted following a syncopal episode. A 2D echo shows markedly dilated left atrium and LVEF 60%. Telemetry reveals atrial fibrillation with slow ventricular response and pauses of 4 to 6 seconds associated with near syncope.
How would you proceed?
Answer: Implant a ventricular rate responsive pacemaker
22. Pacemaker Follow-up GOAL OF FOLLOW-UP
Verify appropriate pacemaker operation
Optimize pacemaker functions
Document findings, changes and final settings in order to provide appropriate patient management
23. Pacemaker – Magnet Application
24. Pacemaker Troubleshooting Failure to capture – high threshold,lead dislodgement, conductor coil fracture
Failure to pace ( failure to output ) – oversensing, circuit interruption, battery depletion
Failure to sense – undersensing, oversensing
25. Intermittent Loss of Ventricular Capture
26. “Pacemaker Syndrome” Fatigue, dizziness, hypotension
Caused by pacing the ventricle asynchronously, resulting in AV dissociation or VA conduction
Mechanism: atrial contraction against a closed AV valve and release of atrial natriuretic peptide
Worsened by increasing the ventricular pacing rate, relieved by lowering the pacing rate or upgrading to dual chamber system
Therapy with fludrocortisone/volume expansion NOT helpful
27. Sources of Electromagnetic Interference Medical
MRI
Lithotripsy
Electrocautery/cryosurgery
External defibrillators
Therapeutic radiation Nonmedical
Arc welding equipment
Automobile engines
Radar Transmitters
28. Expanded Indications for Pacing
Cardiac resynchronization therapy
Hypertrophic cardiomyopathy
Neurocardiogenic syncope?
Long QT syndrome
29. Biventricular Pacing
30. Normal Conduction Is Important Normal conduction allows for prompt and synchronous activation of the atria and ventricles
Results in a brief P wave, PR interval and a narrow QRS
31. Heart Failure - LBBBDelayed Ventricular Activation
32. Heart FailureBifocal Ventricular Pacing
33. Bi-Ventricular Pacing
36. Baseline ECG
37. Bi-V Pace
38. Implantable Cardioverter Defibrillator (ICD)
39. ICD Implantation Secondary prevention: Prevention of SCD in patients with prior VF or sustained VT.
Primary prevention: Prevention of SCD in individuals without a h/o VF or sustained VT.
40. Indications For ICD VF/sustained unstable VT not in the setting of a completely reversible cause.
LVEF = 35%, CHF NYHA class II, III.
Ischemic dilated cardiomyopathy, LVEF = 40%, NSVT and inducible sustained VT.
Syncope, LV dysfunction, inducible sustained VT.
High risk patients with: hypertrophic cardiomyopathy, LQT syndrome, RV dysplasia, Brugada syndrome
42. ACC/AHA/HRS 2008 Guidelines: Systolic Heart Failure - Cardiac Resynchronization Therapy (CRT) Recommendations LVEF = 35%
QRS = 120 msec
NYHA functional Class III or ambulatory Class IV
Optimal medical therapy
43. “Typical Case” 58 year old male, CAD, prior MI 1 year ago, LVEF 28%, CHF NYHA class II, treated with a betablocker, ACE inhibitor and statin; ECG: Sinus rhythm, old anteroseptal MI, QRS 98 msec
Question : For prevention of sudden cardiac death, you would suggest:
A. Treating medically without device implantation
B. Implanting an ICD
C. Implanting an ICD with biventricular pacing capabilities (3 leads)
44. Typical Case
Q: 60 year old female presents with a 1 year h/o non ischemic dilated cardiomyopathy, CHF NYHA class III despite maximum medical therapy, LVEF 20% and LBBB with QRS 170 msec. What device is indicated?
A: Bi-Ventricular ICD
45. 1° Prevention of Sudden Cardiac Death: Clinical Device Algorithm If CAD:
(ACE Inhibitors, Beta Blockers)
46. 1° Prevention: Clinical Device Algorithm If Non –Ischemic Dilated Cardiomyopathy:
47. Primary Prevention Trials: Overall Mortality Reduction With ICD